1. Dalmau J, Graus F: Antibody-Mediated Encephalitis. N Engl J Med 2018, 378:840-851.
2. Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA: Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurol 2016, 73:1297-1307.
3. Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T: The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 2014, 24:83-97.
4. Reindl M, Di Pauli F, Rostásy K, Berger T: The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013, 9:455-461.
5. Pröbstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T: Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflammation 2015, 12:46.
6. Peschl P, Bradl M, Höftberger R, Berger T, Reindl M: Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Front Immunol 2017, 8:529.
7. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
8. Zamvil SS, Slavin AJ: Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2015, 2:e62.
9. Borisow N, Mori M, Kuwabara S, Scheel M, Paul F: Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Front Neurol 2018, 9:888.
10. McKeon A, Benarroch EE: Glial fibrillary acid protein: Functions and involvement in disease. Neurology 2018, 90:925-930.
11. Salama S, Khan M, Shanechi A, Levy M, Izbudak I: MRI differences between MOG antibody disease and AQP4 NMOSD. Mult Scler 2020, 26:1854-1865.
12. Mariano R, Messina S, Kumar K, Kuker W, Leite MI, Palace J: Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease. JAMA Netw Open 2019, 2:e1912732.
13. Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J: Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience. Mult Scler Relat Disord 2021, 48:102718.
14. Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, Tillema JM, Fryer JP, Weinshenker BG, Krecke KN, et al: Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry 2020.
15. Narayan RN, Wang C, Sguigna P, Husari K, Greenberg B: Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Mult Scler Relat Disord 2019, 27:30-33.
16. Yang X, Zhang C, Zhang J, Chen G, Zhao L, Yang P, Li H, Long Y: Autoimmune glial fibrillary acidic protein astrocytopathy mimics infectious meningitis: Two case reports. Mult Scler Relat Disord 2020, 45:102350.
17. Wang JY, Wang K, Chen XW, Wang JW, Zhang K, Xu MW, Luo BY: Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder. Mult Scler 2013, 19:639-643.
18. Xiao J, Chen X, Shang K, Tang Y, Chen M, Deng G, Qin C, Tian DS: Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retrospective study. J Neuroimmunol 2021, 360:577718.
19. Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, et al: MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 2018, 15:134.
20. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, et al: International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015, 85:177-189.
21. Kunchok A, Zekeridou A, McKeon A: Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol 2019, 32:452-458.
22. Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78:665-671; discussion 669.
23. Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, Weinshenker BG, Shosha E, Lucchinetti CF, Fryer JP, et al: Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol 2019, 76:301-309.
24. Wang L, ZhangBao J, Zhou L, Zhang Y, Li H, Li Y, Huang Y, Wang M, Lu C, Lu J, et al: Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. Eur J Neurol 2019, 26:168-174.
25. Otani T, Irioka T, Igarashi S, Kaneko K, Takahashi T, Yokota T: Self-remitting cerebral cortical encephalitis associated with myelin oligodendrocyte glycoprotein antibody mimicking acute viral encephalitis: A case report. Mult Scler Relat Disord 2020, 41:102033.
26. Wang L, Su HJ, Song GJ: A rare case of short-lasting unilateral neuralgiform headache with conjunctival injection and tearing with progression to neuromyelitis optica spectrum disorder. J Int Med Res 2020, 48:300060520964349.
27. Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, et al: Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology 2018, 90:e1858-e1869.
28. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, et al: Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 2017, 140:3128-3138.
29. Höftberger R, Sepulveda M, Armangue T, Blanco Y, Rostásy K, Calvo AC, Olascoaga J, Ramió-Torrentà L, Reindl M, Benito-León J, et al: Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 2015, 21:866-874.
30. de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, Hamann D, Hintzen RQ: The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler 2020, 26:806-814.
31. Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, et al: CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. J Neurol Neurosurg Psychiatry 2018, 89:927-936.
32. Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, et al: Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 2011, 306:82-90.
33. Posner JB, Plum F: Independence of blood and cerebrospinal fluid lactate. Arch Neurol 1967, 16:492-496.
34. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H: A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
35. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349-361.
36. Tao R, Qin C, Chen M, Yu HH, Wu LJ, Bu BT, Tian DS: Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders. Int J Neurosci 2020, 130:1161-1165.
37. Solly SK, Thomas JL, Monge M, Demerens C, Lubetzki C, Gardinier MV, Matthieu JM, Zalc B: Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 1996, 18:39-48.
38. Kim W, Park MS, Lee SH, Kim SH, Jung IJ, Takahashi T, Misu T, Fujihara K, Kim HJ: Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010, 16:1229-1236.
39. Chan KH, Tse CT, Chung CP, Lee RL, Kwan JS, Ho PW, Ho JW: Brain involvement in neuromyelitis optica spectrum disorders. Arch Neurol 2011, 68:1432-1439.